Wilmington Savings Fund Society FSB Cuts Stake in Electromed, Inc. (NYSE:ELMD)

Wilmington Savings Fund Society FSB cut its holdings in shares of Electromed, Inc. (NYSE:ELMD) by 15.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 8,929 shares of the company’s stock after selling 1,600 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Electromed were worth $264,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Hunter Associates Investment Management LLC raised its stake in shares of Electromed by 12.3% in the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock valued at $2,199,000 after acquiring an additional 11,250 shares in the last quarter. Pekin Hardy Strauss Inc. increased its holdings in Electromed by 9.9% during the 3rd quarter. Pekin Hardy Strauss Inc. now owns 38,185 shares of the company’s stock worth $820,000 after purchasing an additional 3,435 shares during the period. Ellsworth Advisors LLC acquired a new stake in Electromed in the 4th quarter valued at about $734,000. State Street Corp boosted its stake in shares of Electromed by 14.5% in the 3rd quarter. State Street Corp now owns 22,066 shares of the company’s stock valued at $474,000 after buying an additional 2,800 shares during the period. Finally, Navellier & Associates Inc. acquired a new position in shares of Electromed during the third quarter worth about $368,000. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Electromed from a “buy” rating to a “strong-buy” rating in a report on Tuesday.

Insider Buying and Selling

In related news, Director Andrew Summers sold 12,731 shares of Electromed stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $29.98, for a total transaction of $381,675.38. Following the sale, the director now directly owns 165,755 shares in the company, valued at $4,969,334.90. This trade represents a 7.13 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 14.00% of the stock is owned by company insiders.

Electromed Trading Down 2.5 %

Electromed stock opened at $29.20 on Wednesday. The company has a fifty day simple moving average of $31.13 and a 200-day simple moving average of $24.45. The stock has a market cap of $247.03 million, a P/E ratio of 40.56 and a beta of 0.33. Electromed, Inc. has a 12-month low of $10.05 and a 12-month high of $35.56.

Electromed (NYSE:ELMD) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.13. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The company had revenue of $14.67 million during the quarter.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.